A phase II, randomized, non-comparative clinical trial of the effect of bevacizumab (BV) alone or in combination with irinotecan (CPT) on 6-month progression free survival (PFS6) in recurrent, treatment-refractory glioblastoma (GBM)
| Image |  |
|---|---|
| Description | article by Timothy F. Cloughesy et al published 20 May 2008 in Journal of Clinical Oncology |
| Author/s | |
| Publication date | May 20, 2008 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |